METTLER-TOLEDO INTERNATIONAL (MTD)
US5926881054 - Common Stock
MTD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. MTD scores excellent on profitability, but there are some minor concerns on its financial health. MTD is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year MTD was profitable.
MTD had a positive operating cash flow in the past year.
Each year in the past 5 years MTD has been profitable.
Each year in the past 5 years MTD had a positive operating cash flow.
1.2 Ratios
MTD has a Return On Assets of 23.97%. This is amongst the best in the industry. MTD outperforms 100.00% of its industry peers.
MTD's Return On Invested Capital of 40.43% is amongst the best of the industry. MTD outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MTD is significantly above the industry average of 10.42%.
The last Return On Invested Capital (40.43%) for MTD is above the 3 year average (39.06%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.97% | ||
| ROE | N/A | ||
| ROIC | 40.43% |
ROA(3y)23.87%
ROA(5y)22.63%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.06%
ROIC(5y)35.9%
1.3 Margins
MTD's Profit Margin of 21.15% is amongst the best of the industry. MTD outperforms 96.36% of its industry peers.
In the last couple of years the Profit Margin of MTD has grown nicely.
With an excellent Operating Margin value of 28.24%, MTD belongs to the best of the industry, outperforming 98.18% of the companies in the same industry.
MTD's Operating Margin has improved in the last couple of years.
MTD has a better Gross Margin (59.48%) than 81.82% of its industry peers.
MTD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 28.24% | ||
| PM (TTM) | 21.15% | ||
| GM | 59.48% |
OM growth 3Y3.43%
OM growth 5Y4%
PM growth 3Y2.15%
PM growth 5Y3.58%
GM growth 3Y0.45%
GM growth 5Y0.61%
2. Health
2.1 Basic Checks
MTD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
MTD has less shares outstanding than it did 1 year ago.
MTD has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MTD is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 9.90 indicates that MTD is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 9.90, MTD belongs to the best of the industry, outperforming 92.73% of the companies in the same industry.
MTD has a debt to FCF ratio of 2.34. This is a good value and a sign of high solvency as MTD would need 2.34 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.34, MTD belongs to the top of the industry, outperforming 85.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.34 | ||
| Altman-Z | 9.9 |
ROIC/WACC3.66
WACC11.06%
2.3 Liquidity
MTD has a Current Ratio of 1.01. This is a normal value and indicates that MTD is financially healthy and should not expect problems in meeting its short term obligations.
MTD has a Current ratio of 1.01. This is amonst the worse of the industry: MTD underperforms 85.45% of its industry peers.
A Quick Ratio of 0.69 indicates that MTD may have some problems paying its short term obligations.
MTD has a Quick ratio of 0.69. This is amonst the worse of the industry: MTD underperforms 90.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
MTD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.45%.
MTD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.34% yearly.
MTD shows a decrease in Revenue. In the last year, the revenue decreased by -3.80%.
Measured over the past years, MTD shows a small growth in Revenue. The Revenue has been growing by 5.23% on average per year.
EPS 1Y (TTM)-6.45%
EPS 3Y14.2%
EPS 5Y13.34%
EPS Q2Q%4.18%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y7.08%
Revenue growth 5Y5.23%
Sales Q2Q%1.28%
3.2 Future
The Earnings Per Share is expected to grow by 10.83% on average over the next years. This is quite good.
Based on estimates for the next years, MTD will show a small growth in Revenue. The Revenue will grow by 3.98% on average per year.
EPS Next Y7.1%
EPS Next 2Y8.04%
EPS Next 3Y9.05%
EPS Next 5Y10.83%
Revenue Next Year0.57%
Revenue Next 2Y2.2%
Revenue Next 3Y3.38%
Revenue Next 5Y3.98%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 31.37, which means the current valuation is very expensive for MTD.
MTD's Price/Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 78.18% of the companies in the same industry.
MTD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.96.
A Price/Forward Earnings ratio of 26.92 indicates a quite expensive valuation of MTD.
MTD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 72.73% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.82, MTD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.37 | ||
| Fwd PE | 26.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
78.18% of the companies in the same industry are more expensive than MTD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.58 | ||
| EV/EBITDA | 22.58 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of MTD may justify a higher PE ratio.
PEG (NY)4.42
PEG (5Y)2.35
EPS Next 2Y8.04%
EPS Next 3Y9.05%
5. Dividend
5.1 Amount
No dividends for MTD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
METTLER-TOLEDO INTERNATIONAL
NYSE:MTD (11/21/2024, 8:04:00 PM)
After market: 1196.82 0 (0%)1196.82
+29.92 (+2.56%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap25.40B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.37 | ||
| Fwd PE | 26.92 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.42
PEG (5Y)2.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 23.97% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 28.24% | ||
| PM (TTM) | 21.15% | ||
| GM | 59.48% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.01 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-6.45%
EPS 3Y14.2%
EPS 5Y
EPS Q2Q%
EPS Next Y7.1%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y7.08%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y